HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Piotr Podolec Selected Research

Heart Diseases (Heart Disease)

11/2016Myocardial Ischaemia, Coronary Atherosclerosis and Pulmonary Pressure Elevation in Antiphospholipid Syndrome Patients.
1/2013Age, sex, and secondary prevention of ischaemic heart disease in everyday practice.
1/2012[Myocardial viability imaging in ischaemic heart disease, part 2: current role of radionuclide imaging. Expert consensus statement of the Polish Clinical Forum for Cardiovascular Imaging].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Piotr Podolec Research Topics

Disease

16Fibrosis (Cirrhosis)
02/2022 - 12/2016
13Coronary Artery Disease (Coronary Atherosclerosis)
01/2022 - 02/2002
12Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
01/2022 - 12/2016
11Heart Failure
09/2021 - 01/2004
9Inflammation (Inflammations)
01/2022 - 11/2003
9Atherosclerosis
01/2022 - 01/2002
9Hypertension (High Blood Pressure)
01/2021 - 01/2011
8Atrial Fibrillation
01/2021 - 01/2002
8Atrial Heart Septal Defects (Atrial Septal Defect)
05/2018 - 01/2004
7Pulmonary Hypertension
01/2022 - 01/2004
7Cardiovascular Diseases (Cardiovascular Disease)
03/2021 - 05/2007
7Pathologic Constriction (Stenosis)
08/2016 - 01/2002
6Acute Coronary Syndrome
01/2021 - 01/2011
6Stroke (Strokes)
10/2020 - 04/2009
5Pulmonary Arterial Hypertension
01/2020 - 11/2012
5Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy)
01/2020 - 01/2006
5Myocardial Infarction
01/2017 - 10/2004
4Endocarditis
07/2022 - 01/2020
4Infarction (Infarctions)
01/2015 - 10/2004
4Aortic Valve Stenosis (Aortic Stenosis)
07/2004 - 01/2002
3Thromboembolism
01/2022 - 04/2014
3Left Ventricular Dysfunction
09/2021 - 01/2011
3Infections
01/2020 - 02/2003
3Carotid Stenosis (Carotid Artery Stenosis)
07/2019 - 07/2013
3Familial Primary Pulmonary Hypertension
01/2019 - 03/2017
3Neoplasms (Cancer)
06/2017 - 12/2016
3Heart Diseases (Heart Disease)
11/2016 - 01/2012
3Thrombosis (Thrombus)
04/2014 - 01/2012
3Ischemic Stroke
12/2009 - 04/2009
3Pain (Aches)
01/2008 - 09/2004
3Mitral Valve Insufficiency (Mitral Regurgitation)
07/2004 - 01/2002
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2022 - 07/2011
2Hemorrhage
01/2021 - 10/2019
2Bradycardia
01/2021 - 01/2012
2Pulmonary Embolism
01/2021 - 01/2021
2Overweight
01/2021 - 01/2015
2Bundle-Branch Block (Fascicular Block)
10/2020 - 01/2002
2Diabetes Mellitus
10/2020 - 08/2016
2Aortic Coarctation
12/2019 - 05/2018
2Congenital Heart Defects (Congenital Heart Defect)
01/2019 - 02/2015
2Univentricular Heart
05/2018 - 10/2017
2Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
11/2016 - 08/2016
2Atherosclerotic Plaque (Atheroma)
07/2013 - 10/2011

Drug/Important Bio-Agent (IBA)

14Biomarkers (Surrogate Marker)IBA
03/2021 - 01/2011
7CollagenIBA
01/2022 - 11/2003
7CalciumIBA
11/2016 - 01/2002
6GadoliniumIBA
02/2022 - 01/2008
6LDL CholesterolIBA
08/2018 - 01/2002
5Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2022 - 01/2004
5MicroRNAs (MicroRNA)IBA
01/2022 - 03/2017
5Glucose (Dextrose)FDA LinkGeneric
01/2021 - 01/2014
5procollagen Type III-N-terminal peptide (PIIP)IBA
01/2020 - 12/2016
5procollagen type I carboxy terminal peptide (PICP)IBA
01/2020 - 12/2016
5Connective Tissue Growth FactorIBA
01/2020 - 12/2016
4Collagen Type I (Type I Collagen)IBA
01/2020 - 12/2016
4Peptides (Polypeptides)IBA
03/2018 - 12/2016
4Creatine Kinase (Creatine Phosphokinase)IBA
08/2009 - 09/2004
3OximesIBA
07/2022 - 01/2020
3C-Reactive ProteinIBA
01/2022 - 01/2011
3Interleukin-6 (Interleukin 6)IBA
01/2022 - 01/2011
3Antiphospholipid AntibodiesIBA
01/2022 - 11/2016
3Immunoglobulin G (IgG)IBA
01/2022 - 02/2003
3pro-brain natriuretic peptide (1-76)IBA
01/2021 - 01/2011
3lipoprotein cholesterolIBA
01/2021 - 01/2018
3ThrombinFDA Link
01/2020 - 03/2005
3Transforming Growth Factors (Transforming Growth Factor)IBA
01/2020 - 01/2017
3FibrinIBA
01/2020 - 04/2009
3Fibrinogen (Factor I)FDA Link
12/2019 - 01/2002
3CholesterolIBA
12/2019 - 01/2011
3CytokinesIBA
01/2019 - 01/2011
3LipidsIBA
01/2019 - 01/2002
3Matrix Metalloproteinases (MMPs)IBA
03/2018 - 12/2016
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
06/2017 - 12/2016
3Endothelin-1 (Endothelin 1)IBA
08/2014 - 01/2004
3Phosphotransferases (Kinase)IBA
01/2008 - 09/2004
2Galectin 3 (LGALS3)IBA
03/2021 - 01/2020
2Tissue Plasminogen Activator (Alteplase)FDA Link
01/2021 - 01/2013
2Troponin T (Troponin T1)IBA
01/2021 - 01/2015
2Indicators and Reagents (Reagents)IBA
01/2021 - 11/2014
2Angiotensin Receptors (Angiotensin II Receptor)IBA
11/2020 - 01/2017
2Neprilysin (Neutral Endopeptidase)IBA
11/2020 - 01/2017
2Brain Natriuretic Peptide (Natrecor)FDA Link
10/2020 - 05/2018
2Proteins (Proteins, Gene)FDA Link
01/2020 - 03/2018
2AnticoagulantsIBA
01/2019 - 01/2018
2Procollagen Type IIBA
03/2018 - 12/2016
2Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2012 - 01/2004

Therapy/Procedure

12Therapeutics
07/2022 - 01/2006
7Myocardial Revascularization
01/2021 - 01/2015
6Fontan Procedure (Fontan Operation)
01/2019 - 04/2014
6Septal Occluder Device
12/2009 - 01/2004
5Secondary Prevention
12/2020 - 01/2013
5Percutaneous Coronary Intervention
01/2015 - 04/2004
5Heart Transplantation (Grafting, Heart)
01/2006 - 01/2002
4Coronary Artery Bypass (Coronary Artery Bypass Surgery)
09/2021 - 12/2010
4Catheters
01/2021 - 02/2012
4Stents
07/2019 - 01/2012
3Endarterectomy (Thromboendarterectomy)
01/2022 - 08/2016
3Contraindications
01/2020 - 01/2006
2Heart-Assist Devices
01/2018 - 01/2004
2Cardiac Rehabilitation
06/2016 - 08/2015